AAV vectors, the future workhorse of human gene therapy.

[1]  Juan Li,et al.  A Novel Gene Expression Control System and Its Use in Stable, High-Titer 293 Cell-Based Adeno-Associated Virus Packaging Cell Lines , 2002, Journal of Virology.

[2]  Juan Li,et al.  Feasibility of Generating Adeno-Associated Virus Packaging Cell Lines Containing Inducible Adenovirus Helper Genes , 2002, Journal of Virology.

[3]  R. Samulski,et al.  Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity , 2002, Journal of Virology.

[4]  R. Samulski,et al.  Building a better vector: the manipulation of AAV virions. , 2000, Virology.

[5]  R. Samulski,et al.  Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  R. Samulski,et al.  Adeno-associated virus vectors for gene therapy: more pros than cons? , 2000, Molecular medicine today.

[7]  R. Kotin,et al.  Adeno-Associated Virus Type 5 (AAV5) but Not AAV2 Binds to the Apical Surfaces of Airway Epithelia and Facilitates Gene Transfer , 2000, Journal of Virology.

[8]  R. Samulski,et al.  The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers. , 2000, Human gene therapy.

[9]  Alan McClelland,et al.  Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector , 2000, Nature Genetics.

[10]  R. Samulski,et al.  AAV vectors: is clinical success on the horizon? , 2000, Gene Therapy.

[11]  B. Byrne,et al.  Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield , 1999, Gene Therapy.

[12]  James M. Wilson,et al.  Gene Therapy Vectors Based on Adeno-Associated Virus Type 1 , 1999, Journal of Virology.

[13]  R. Samulski,et al.  Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus , 1998, Journal of Virology.

[14]  R. Samulski,et al.  Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.

[15]  R. Samulski,et al.  Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia , 1998, Gene Therapy.

[16]  R. Samulski,et al.  Role for highly regulated rep gene expression in adeno-associated virus vector production , 1997, Journal of virology.

[17]  R. Samulski,et al.  Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector , 1996, Journal of virology.

[18]  R. Samulski.  Adeno-associated virus: integration at a specific chromosomal locus. , 1993, Current opinion in genetics & development.

[19]  N. Muzyczka.  Use of adeno-associated virus as a general transduction vector for mammalian cells. , 1992, Current topics in microbiology and immunology.

[20]  Samulski,et al.  Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression , 1989, Journal of virology.